Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy

Trends in cancer(2025)10.1016/j.trecan.2025.08.003Source: DataRank Database

Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy is a research paper published in Trends in cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: greenTopics (45)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Gagan Chhabra ORCID,Nihal Ahmad ORCID,Tanya Jaiswal

Live enrichment

PubMed:40885612 OpenAlex:https://openalex.org/W4413831686

U.S. Department of Veterans Affairs

Grant: CSR&D I01CX002210

U.S. Department of Veterans Affairs

Grant: IK6BX006041

U.S. Department of Veterans Affairs

Grant: I01BX005917

National Institutes of Health National Cancer Institute

Grant: R01CA261937

CSRD VA

Grant: I01 CX002210

US Department of Veterans Affairs

Grant: CSR&amp;D I01CX002210

National Institutes of Health

University of Wisconsin Foundation

FWCI

0.00

Citation Percentile

0.3%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12403973/

publisherhttps://api.elsevier.com/content/article/PII:S2405803325002018?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803325002018?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trecan.2025.08.003

Fields of Study

Chronic Lymphocytic Leukemia ResearchMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins ResearchHumansNeoplasmsProtein Serine-Threonine KinasesPolo-Like Kinase 1ImmunotherapyProto-Oncogene ProteinsCell Cycle ProteinsProtein Kinase InhibitorsImmune Checkpoint InhibitorsAnimalsDrug Resistance, NeoplasmPolo-like Kinases

MeSH Terms

Immune Checkpoint InhibitorsPolo-like KinasesPolo-Like Kinase 1AnimalsHumansImmunotherapyNeoplasmsProto-Oncogene ProteinsProtein Serine-Threonine KinasesCell Cycle ProteinsDrug Resistance, NeoplasmProtein Kinase Inhibitors

Keywords

ImmunotherapyFrontierCancer immunotherapyCancerImmune systemKinaseCancer researchBiologyMedicineImmunologyCell biologyPolitical scienceInternal medicineFASIFNPD-L1TGF-βPlk